基于FAERS数据库的信号检测和分析与Genvoya®相关的不良事件
Chengliang Wang1, Yan Zhang1, Xiting Tang1
1People's Hospital of Ganzi Tibetan Autonomous Prefecture, Kangding, Sichuan, China.
Frontiers in pharmacology
|December 19, 2024
概括
这项研究分析了FDA不良事件报告系统对Genvoya®的数据,确定体重增加,药物相互作用和病毒载量增加是艾滋病毒患者常见的不良药物事件.
科学领域:
- 药物监督 药物监督 药物监督
- 艾滋病毒/艾滋病治疗药物 治疗药物
- 药品安全 药品安全
背景情况:
- Genvoya®是治疗艾滋病毒的关键抗逆转录病毒药物.
- 了解其现实世界的安全概况对于患者护理至关重要.
- 美国食品和药物管理局的不良事件报告系统 (FAERS) 为市场后监测提供了宝贵的数据来源.
研究的目的:
- 使用FAERS数据评估Genvoya®的安全性.
- 为了确定与Genvoya®相关的潜在不良药物事件 (ADEs) 和不良反应.
- 为艾滋病毒治疗提供安全参考.
主要方法:
- 从FAERS数据库 (2015年第一季度 - 2023年第四季度) 中分析了2,376份ADE报告.
- 专注于Genvoya®是首要疑似药物的报告.
- 使用报告几率比率 (ROR) 和MHRA方法进行不成比例分析.
主要成果:
- 常见的ADEs包括体重增加,药物相互作用和病毒载量增加.
- 确定了新的潜在不良反应:脂肪再分配,与艾滋病毒相关的神经认知障碍和脑膜炎.
- 这些反应在现有的文献或药物标签上没有得到充分记录.
结论:
- 使用Genvoya®与多种不良反应有关.
- 临床医生必须密切监测患者是否存在这些潜在风险.
- FAERS数据分析为Genvoya®在艾滋病管理中的安全性提供了关键的见解.
更多相关视频
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
371
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
4.9K
相关概念视频
Pharmacovigilance
773
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
773
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Antiepileptic Drugs: Potassium Channel Activators
143
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
143
Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K
